Sarcoidal anemia and leukopenia treated with methotrexate and mycophenolate mofetil

Archives of Dermatology

Volumn 145, Issue 8, 2009, Pages 905-909

  Kalajian, Andrew H ^a   Van Meter, Jonathan R ^a   Callen, Jeffrey P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DOXYCYCLINE HYCLATE; FOLIC ACID; HYDROXYCHLOROQUINE SULFATE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AFRICAN AMERICAN; ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; DRUG DOSE ESCALATION; DRUG SUBSTITUTION; FATIGUE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LUNG DIFFUSION CAPACITY; LYMPHOCYTIC INFILTRATION; MALE; PAROTID ENLARGEMENT; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; SARCOIDOSIS; TREATMENT OUTCOME;

ADULT; ANEMIA; BONE MARROW DISEASES; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOPENIA; MALE; METHOTREXATE; MYCOPHENOLIC ACID; SARCOIDOSIS; SKIN DISEASES;

EID: 68949122636     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.75     Document Type: Article

References (23)

1. du Bois RM, Goh N, McGrath D, Cullinan P. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Intern Med. 2003;253(1):4-17.
2. Smith G, Brownell I, Sanchez M, Prystowsky S. Advances in the genetics of sarcoidosis. Clin Genet. 2008;73(5):401-412.
3. Longcope WT, Freiman DG. A study of sarcoidosis: based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore). 1952;31(1):1-132.
4. Yanardaǧ H, Pamuk GE, Karayel T, Demirci S. Bone marrow involvement in sarcoidosis: an analysis of 50 bone marrow samples. Haematologia (Budap). 2002;32(4):419-425.
5. Bodem CR, Hamory BH, Taylor HM, Kleopfer L. Granulomatous bone marrow disease: a review of the literature and clinicopathologic analysis of 58 cases. Medicine (Baltimore). 1983;62(6):372-383.
6. Lower EE, Smith JT, Martelo OJ, Baughman RP. The anemia of sarcoidosis. Sarcoidosis. 1988;5(1):51-55.
7. Baughman RP, Winget DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis. 2000;17(1):60-66.
8. Badgwell C, Rosen T. Cutaneous sarcoidosis therapy updated. JAmAcad Dermatol. 2007;56(1):69-83.
9. Baughman RP, Lower EE. Novel therapies for sarcoidosis. Semin Respir Crit Care Med. 2007;28(1):128-133.
10. Lacher MJ. Spontaneous remission or response to methotrexate in sarcoidosis. Ann Intern Med. 1968;69(6):1247-1248.
11. Veien NK, Brodthagen H. Cutaneous sarcoidosis treated with methotrexate. Br J Dermatol. 1977;97(2):213-216.
12. Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax. 1999;54(8):742-746.
13. Seitz M. Molecular and cellular effects of methotrexate. Curr Opin Rheumatol. 1999;11(3):226-232.
14. Kilmartin DJ, Forrester JV, Dick AD. Rescue therapy with mycophenolate mofetil in refractory uveitis. Lancet. 1998;352(9121):35-36.
15. Kouba DJ, Mimouni D, Rencic A, Nousari HC. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis. Br J Dermatol. 2003;148(1):147-148.
16. O'Connor AS, Navab F, Germain MJ, et al. Pancreatitis and duodenitis from sarcoidosis: successful therapy with mycophenolate mofetil. Dig Dis Sci. 2003;48(11):2191-2195.
17. Moudgil A, Przygodzki RM, Kher KK. Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil. Pediatr Nephrol. 2006;21(2):281-285.
18. Lipsky JJ. Mycophenolate mofetil. Lancet. 1996;348(9038):1357- 1359.
19. Baughman RP, Ohmichi M, Lower EE. Combination therapy for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2001;18(2):133-137.
20. Pia G, Pascalis L, Aresu G, Rosetti L, Ledda MA. Evaluation of the efficacy and toxicity of the cyclosporine A-flucortolone-methotrexate combination in the treatment of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1996;13(2):146-152.
21. Kennedy D, Yamakido M. Hematologic manifestations of sarcoidosis. Semin Respir Med. 1992;13(6):455-458.
22. DeRemee RA, Rohrbach MS. Serum angiotensin-converting enzyme activity in evaluating the clinical course of sarcoidosis. Ann Intern Med. 1980;92(3):361-365.
23. Lieberman J, Schleissner LA, Nosal A, Sastre A, Mishkin FS. Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis: a longitudinal study of serum ACE, 67 gallium scans, chest roentgenograms, and pulmonary function. Chest. 1983;84(5):522-528.